Form 8-K Aravive, Inc. For: Nov 20

Go back to Form 8-K Aravive, Inc. For: Nov 20

Aravive Inc. (ARAV) PT Raised to $31 at H.C. Wainwright

November 20, 2019 12:14 PM EST

H.C. Wainwright analyst Joseph Pantginis raised the price target on Aravive Inc. (NASDAQ: ARAV) to $31.00 (from $18.00) while maintaining a Buy rating.

The analyst commented, "This morning, Aravive announced new positive data from the ongoing Phase 1b portion of the Phase 1b/2 clinical trial of... More

Aravive Inc. (ARAV) Halted on LUDP

November 20, 2019 9:46 AM EST

Aravive Inc. (NASDAQ: ARAV) Halted on LUDP

... More

Aravive Inc. (ARAV) Extends Gain, Up 250%

November 20, 2019 7:43 AM EST

Aravive Inc. (NASDAQ: ARAV) Extends Gain, Up 250%

... More